Chronic prostatitis: a new paradigm of treatment


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

This paper proposes health care recommendations for men with chronic prostatitis (CP) taking into account etiopathogenesis and the clinical presentation of the disease. The proposal is based on the experience of federal and regional clinics of urology and gynecology, respective departments for postgraduate education and on the analysis of scientific literature. It is shown that managing patients with CP requires consideration of factors beyond the traditional practice of urology. The author validates the need to use the modern prostatitis classification UPOINT instead of the traditional NIH NIDDK (1995) to increase the effectiveness of treatment. It is demonstrated that the concurrent use of medications and non-pharmacological treatments aimed at different aspects of the state improve the treatment effectiveness. Indications are refined for medical and non-pharmacological treatments: antibiotics, alpha-blockers, anticholinergic agents, analgesics, antidepressants, herbal remedies, pelvic floor physiotherapy, psychotherapy. The shortcomings and mistakes of existing guidelines/standards are analyzed.

Full Text

Restricted Access

About the authors

V. A Bozhedomov

Peoples’ Friendship University of Russia; I.M. Sechenov First MSMU

Email: vbojedomov@mail.ru
Department of Clinical Andrology, FATHCW of Medical Institute; Department of Obstetrics, Gynecology, Perinatology and Reproductology

References

  1. Урология. Российские клинические рекомендации / Под ред. Аляева Ю.Г., Глыбочко П.В., Пушкаря Д.Ю. Гэотар-Медиа, 2015. 480 с
  2. Smith C.P. Male chronic pelvic pain: An update. Indian J Urol. 2016, 32: 34-39.
  3. Polackwich A.S., Shoskes D.A. Chronic prostatitis/chronic pelvic pain syndrome: a review of evaluation and therapy. Prostate Cancer Prostatic Dis. 2016 Jun; 19(2):132-138.
  4. Rees J., Abrahams M., Doble A., Cooper A. for the Prostatitis Expert Reference Group (PERG). Diagnosis and treatment of chronic bacterial prostatitis and chronic prostatitis/chronic pelvic pain syndrome: a consensus guideline. BJU Int. 2015;116:509-525.
  5. Wagenlehner F., vanTill O., Magri V. et al. National Institute of Health Chronic Prostatitis Symptom Index (CPSI) symptom evaluation in patients with chronic prostatitis / chronic pelvic pain syndrome - A multinational study in 1,563 patients. Presented at AUA 2012, abstract #1082.
  6. Anothaisintawee T., Attia J., Nickel J.C., Thammakraisorn S., Numthavaj P., McEvoy M., Thakkinstian A. Management of chronic prostatitis/chronic pelvic pain syndrome: a systematic review and network meta-analysis. JAMA. 2011;305:78-86.
  7. Krieger J.N., Lee S.W., Jeon J., Cheah P.Y., Liong M.L., Riley D.E. Epidemiology of prostatitis. International journal of antimicrobial agents. 2008;31(Suppl. 1):S85-90.
  8. Grabe M. (Chair), R. Bartoletti, T.E. Bjerklund Johansen, et al. Guidelines on urological infections© European Association of Urology. 2015:40-46.
  9. Hatzimouratidis K. (Chair), I. Eardley, F. Giuliano, I. et al. Guidelines on male sexual dysfunction: Erectile Dysfunction and Premature Ejaculation © European Association of Urology 2015: 145-160.
  10. Weidner W., Diemer Th., Wagenlehner F. Male urogenital infections. Clinical Uro-Andrology. (ed) V. Mirone: Springer-Verlag Berlin Heidelberg. 2015:205-212.
  11. McNaughton Collins M., Pontari M.A., O’Leary M.P., Calhoun E.A., Santanna J., Landis J.R., Kusek J.W., Litwin M.S. Chronic Prostatitis Collaborative Research Network. Quality of life is impaired in men with chronic prostatitis: The Chronic Prostatitis Collaborative Research Network. J Gen Intern Med. 2001;16: 656-662.
  12. Lotti F., Corona G., Mondaini N., Maseroli E., Rossi M., Filimber-ti E., Noci I., Forti G., Maggi M. Seminal, clinical and colour-Doppler ultrasound correlations of prostatitis-like symptoms in males of infertile couples. Andrology. 2014;2:30-41.
  13. Krieger J.N., Thumbikat P. Bacterial Prostatitis: Bacterial Virulence, Clinical Outcomes, and New Directions. Microbiol Spectr. 2016; 4(1). doi: 10.1128/microbiolspec.UTI-0004-2012.
  14. Choi Y.S., Kim K.S., Choi S.W., Kim S., Bae W.J., Cho H.J., Hong S.H., Kim S.W., Hwang T.K., Lee J.Y. Microbiological etiology of bacterial prostatitis in general hospital and primary care clinic in Korea. Prostate Int. 2013; 1:133-138.
  15. Божедомов В.А., Семенов А.В., Конышев А.В., Липатова Н.А., Пацановская Г.М., Божедомова Г.Е., Третьяков А.В. Репродуктивная функция мужчин при хроническом простатите: клинико-анамнестические и микробиологические аспекты. Урология. 2015;1:70-78
  16. Nickel JC. Prostatitis. Can Urol Assoc J 2011;5:306-315.
  17. Chen X., Hu C., Peng Y., Lu J., Yang N.Q., Chen L., Zhang G.Q., Tang L.K., Dai J.C. Association of diet and lifestyle with chronic prostatitis/chronic pelvic pain syndrome and pain severity: a case-control study. Prostate Cancer Prostatic Dis. 2016;19:92-99.
  18. Magri V., Marras E., Restelli A., Wagenlehner F.M., Perletti G. Multimodal therapy for category III chronic prostatitis/chronic pelvic pain syndrome in UPOINTS phenotyped patients. Exp Ther Med. 2015;9:658-666.
  19. Shoskes D.A., Nickel J.C., Kattan M.W. Phenotypically directed multimodal therapy for chronic prostatitis/chronic pelvic pain syndrome: a prospective study using UPOINT. Urology. 2010;75:1249-53.
  20. Engeler D. (Chair), A.P. Baranowski, J. Borovicka et al. EAU guidelines on chronic pelvic pain. Guidelines of the European Association of Urology, 2016.
  21. Стандарт первичной медико-санитарной помощи при хроническом простатите [Приложение к приказу Министерства здравоохранения РФ №775н oт 09.11.2012]
  22. Bruce A.W., Reid G. Prostatitis associated with Chlamydia trachomatis in 6 patients. J Urol. 1989;142(4):1006
  23. Poletti F.,Medici M.C.,Alinovi A.,Menozzi M.G.,Sacchini P.,Stagni G., Toni M., Benoldi D. Isolation of Chlamydia trachomatis from the prostatic cells in patients affected by nonacute abacterial prostatitis. J Urol. 1985;134(4):691.
  24. Коган М.И., Белоусов И.И., Болоцков А.С. Артериальный кровоток в простате при синдроме хронической тазовой боли/хроническом простатите. Урология. 2011; 3:22-28
  25. Kelley K.J. FDA calls for more restriction on fluoroquinolone use. Medical news. Physicians first watch. Ed. S. Sadoughi, A. Sofair. May16, 2016.
  26. FDA Drug Safety Communication: FDA advises restricting fIuoroquinoIone antibiotic use for certain uncompIicated infections; warns about disabIing side effects that can occur together May 12, 2016. Информация доступна на сайте: http://www.fda.gov/ Drugs/DrugSafety/ucm500143.htm (дата обращения: 27.05.2016).
  27. Винаров А.З., Стойлов С.В., Козырев С.В., Суриков В.Н., Чабан А.В., Курбатов Д.Г., Шпиленя Е.С., Неймарк А.И. Лечение больных простатитом доксициклином (Юнидокс Солютаб®) и/ или джозамицином (Вильпрафен®) в реальной клинической практике. Результаты наблюдательной программы TAURUS. Урология. 2015;3:75-83
  28. Mishra V.C., Browne J., Emberton M. Role of repeated prostatic massage in chronic prostatitis: a systematic review of the literature. UroIogy. 2008;72:731-735
  29. Thakkinstian A., Attia J., Anothaisintawee T., Nickel J.C. а-bIockers, antibiotics and anti-infIammatories have a roIe in the management of chronic prostatitis/chronic pelvic pain syndrome. BJU Int. 2012;110:1014-1022.
  30. Cohen J.M., Fagin A.P., Hariton E., Niska J.R., Pierce M.W., Kuriyama A., Whelan J.S., Jackson J.L., Dimitrakoff J.D. Therapeutic intervention for chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS): a systematic review and meta-analysis. PLoS One. 2012;7(8):e41941.
  31. Chiang P.H., Chiang C.P. Therapeutic effect of transurethral needle abIation in non-bacteriaI prostatitis: chronic peIvic pain syndrome type IIIa. InternationaI journaI of uroIogy: officiaI journaI of the Japanese Urological Association. 2004;11:97-102.
  32. Kastner C., Hochreiter W., Huidobro C., Cabezas J., Miller P. CooIed transurethraI microwave thermotherapy for intractabIe chronic prostatitis - resuIts of a piIot study after 1 year. UroIogy. 2004;64:1149-1154.
  33. Пушкарь Д.Ю., Зайцев А.В., Раснер П.И. Оптимизация алгоритма диагностики и лечения хронического бактериального простатита. РМЖ. 2008;16(17):34-38
  34. Гаджиева З.К., Казилов Ю.Б. Обоснование комбинированной медикаментозной терапии симптомов нижних моче-выводящих путей с использованием a1-адреноблокатора и м-холиноблокатора. Урология. 2016; 1:91-98
  35. Nickel J.C., Roehrborn C., Montorsi F., Wilson T.H., Rittmaster R.S. Dutasteride reduces prostatitis symptoms compared with placebo in men enrolled in the REDUCE study. J Urol. 2011;186:1313-1318.
  36. Clemens J.Q., Nadler R.B., Schaeffer A.J., Belani J., Albaugh J., Bushman W. Biofeedback, peIvic fIoor re-education, and bIadder training for male chronic pelvic pain syndrome. Urology. 2000;20:56:951-955.
  37. Cornel E.B., van Haarst E.P., Schaarsberg R.W., Geels J. The effect of biofeedback physicaI therapy in men with Chronic PeIvic Pain Syndrome Type III. European urology. 2005 May: 47:607-611.
  38. He W., Chen M., Zu X., Li Y., Ning K., Qi L. Chronic prostatitis presenting with dysfunctional voiding and effects of pelvic floor biofeedback treatment. BJU international. 2010;105:975-77.
  39. Ginting J.V., Tripp D.A., Nickel J.C. Self-reported spousal support modifies the negative impact of pain on disabiIity in men with chronic prostatitis/chronic pelvic pain syndrome. Urology. 2011;78: 1136-1141.
  40. Falahatkar S., Shahab E., Gholamjani Moghaddam K., Kazemnezhad E. Transurethral intraprostatic injection of botulinum neurotoxin type A for the treatment of chronic prostatitis/chronic pelvic pain syndrome: ResuIts of a prospective piIot doubIe-bIind and randomized placebo-controlled study. BJU Int. 2015;116:641-649.
  41. Wagenlehner F.M., Schneider H., Ludwig M., Schnitker J., Brähler E., Weidner W. A pollen extract (Cernilton) in patients with inflammatory chronic prostatitis-chronic peIvic pain syndrome: A muIticentre, randomised, prospective, doubIe-bIind, pIacebo-controIIed phase 3 study. Eur Urol. 2009;56:544-551.
  42. Elist J. Effects of pollen extract preparation Prostat/Poltit on Iower urinary tract symptoms in patients with chronic nonbacteriaI prostatitis/chronic pelvic pain syndrome: a randomized, double-bIind, pIacebo-controIIed study. UroIogy. 2006;67:60-63.
  43. Morgia G., Mucciardi G., Gali A., Madonia M., Marchese F., Di Benedetto A., Romano G., Bonvissuto G., Castelli T., Macchione L., Magno C. Treatment of chronic prostatitis/chronic pelvic pain syndrome category IIIA with Serenoa repens plus selenium and lycopene (Profluss) versus S. repens alone: an Italian randomized multicenter-controlled study. Urologia internationalis. 2010;84: 400-406.
  44. Cai T., Mazzoli S., Bechi A., Addonisio P., Mondaini N., Pagliai R.C., Bartoletti R. Serenoa repens associated with Urtica dioica (ProstaMEV) and curcumin and quercitin (FIogMEV) extracts are abIe to improve the efficacy of pruIifIoxacin in bacteriaI prostatitis patients: resuIts from a prospective randomised study. Int J Antimicrob Agents. 2009;33:549-553.
  45. Perletti G., Marras E., Wagenlehner F.M., Magri V. Antimicrobial therapy for chronic bacteriaI prostatitis. Cochrane Database Syst Rev. 2013;8: CD009071.
  46. Lanjouw E. et al. European guideIine for the management of ChIamydia trachomatis infections. Int J STD AIDS. 2015 Nov 24.
  47. Centers for Disease Control and Prevention. MMWR Recommendations and Reports. SexuaIIy transmitted disease treatment guidelines. 2015;64(3):1-140.
  48. Kong F.Y., Tabrizi S.N., Fairley C.K., Vodstrcil L.A., Huston W.M., Chen M., Bradshaw C., Hocking J.S. The efficacy of azithromycin and doxycycIine for the treatment of rectaI ChIamydia infection: a systematic review and meta-analysis. J Antimicrob Chemother. 2015;70:1290-1297.
  49. Kong F.Y., Tabrizi S.N., Law M., Vodstrcil L.A., Chen M., Fairley C.K., Guy R., Bradshaw C., Hocking J.S. Azithromycin Versus Doxycycline for the Treatment of Genital Chlamydia Infection: A Meta-analysis of Randomized Controlled Trials. Clinical Infectious Diseases. 2014;59(2):193-205.
  50. Рафальский В.В. и соавт. Сравнение эффективности доксициклина и азитромицина при хламидийном уретрите у мужчин: мета-анализ рандомизированных исследований. ConsiIium medicum 2008. 04. Информация доступна на сайте http://con-med.ru/ magazines/consiIium_medicum/consiIium_medicum-04-2008/ sravnenie_effektivnosti_doksitsikIina_i_azitromitsina_pri_ khIamidiynom_uretrite_u_muzhchin_metaanaIi/ [дата обращения 28.05.2016]
  51. Huang C., Long X., Jing S., Fan L., Xu K., Wang S., Zhu W. Ureaplasma urealyticum and Mycoplasma hominis infections and semen quality in 19,098 infertile men in China. World J Urol. 2015 Nov 4.
  52. Kouegnigan Rerambiah L., Ndong J.C., Medzegue S., Elisee-Ndam M., Djoba Siawaya J.F. Genital Mycoplasma infections and their resistance phenotypes in an African setting. Eur J Clin Microbiol Infect Dis. 2015;34(6):1087-1090.
  53. Zhang Z.C., Jin F.S., Liu D.M., Shen Z.J., Sun Y.H., Guo Y.L. Safety and efficacy of levofloxacin versus ciprofloxacin for the treatment of chronic bacterial prostatitis in Chinese patients. Asian J Androl. 2012;14:870-74
  54. Научный отчет о результатах многоцентрового исследования динамики антибиотикорезистентности возбудителей инфекций мочевых путей в различных субпопуляциях пациентов («ДАРМИС»). Смоленск, 2011. 118 с
  55. Pontari M.A., Krieger J.N., Litwin M.S., White P.C., Anderson R.U., McNaughton-Collins M., Nickel J.C., Shoskes D.A., Alexander R.B., O’Leary M., Zeitlin S., Chuai S., Landis J.R., Cen L., Propert K.J., Kusek J.W., Nyberg L.M. Jr, Schaeffer A.J.; Chronic Prostatitis Collaborative Research Network-2. Pregabalin for the treatment of men with chronic prostatitis/chronic pelvic pain syndrome: A randomized controlled trial. Arch Intern Med. 2010; 170:1586-1593
  56. Камалов А.А., Низов А.Н., Ходырева Л.А., Дударева А.А. Эффективность методов электро- и магнитной стимуляции у больных синдромом хронической тазовой боли, гиперактивным мочевым пузырем в урологической практике (обзор литературы). Урология. 2014;4:96-99
  57. Руденко В.И., Рапопорт Л.М., Газимиев М.А., Демидко Ю.Л., Байдувалиев А.М. Первый опыт применения ударно-волновой терапии у мужчин с синдромом хронической тазовой боли. Урология. 2015;6:26-29
  58. Gottsch H.P., Yang C.C., Berger R.E. A pilot study of botulinum toxin A for male chronic pelvic pain syndrome. Scand J Urol Nephrol. 2011; 45: 72-76
  59. Тюзиков И.А., Греков Е.А., Калинченко С.Ю., Мартов А.Г. Оптимизация диагностики воспалительных заболеваний предстательной железы на основе междисциплинарного подхода. Экспериментальная и клиническая урология. 2013;1:44-51
  60. Samplaski M.K., Li J., Shoskes D.A. Clustering of UPOINT domains and subdomains in men with chronic prostatitis/chronic pelvic pain syndrome and contribution to symptom severity. J Urol. 2012;188:1788-1793
  61. Яровой С.К. Место фосфомицина в медикаментозной терапии заболеваний мочеполовой системы. Экспериментальная и клиническая урология. 2013;4:115-120
  62. Перепанова Т.С., Козлов Р.С., Руднов В.А., Синякова Л.А. Обновленные Российские национальные рекомендации по антимикробной терапии и профилактике инфекций почек, мочевыводящих путей и мужских половых органов. 2014
  63. Cai T., Tiscione D., Malossini G., et al. Antimicrobial prophylaxis for transrectal ultrasound-guided prostate biopsy: Fosfomycin trometamol is an attractive strategy. Poster 267, EAU16, Munich
  64. Gill B.C., Shoskes D.A. Bacterial prostatitis. Curr Opin Infect Dis. 2016;29:86-91
  65. Ефремов Е.А., Дорофеев С.Д., Мельник Я.И., Касатонова Е.В., Симаков В.В., Красняк С.С. Снижение продолжительности курса антибактериальной терапии за счет повышения суточной дозы при лечении хронического бактериального простатита. Экспериментальная и клиническая урология. 2014;1:44-48

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies